Psychemedics Cash Flow from Investing Activities 2010-2024 | PMD

Psychemedics cash flow from investing activities from 2010 to 2024. Cash flow from investing activities can be defined as the total change in cash resulting from a companies investments
Psychemedics Annual Cash Flow Investing
(Millions of US $)
2023 $-0
2022 $-0
2021 $-0
2020 $-1
2019 $2
2018 $-5
2017 $-1
2016 $-2
2015 $-2
2014 $-8
2013 $-2
2012 $-2
2011 $1
2010 $-2
2009 $-1
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.015B $0.022B
Psychemedics Corporation provides testing services for the detection of abused substances through the analysis of hair samples. Their testing methods utilize a patented technology for performing immunoassays on enzymatically dissolved hair samples with confirmation testing by mass spectrometry.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $17.403B 10.53
Quest Diagnostics (DGX) United States $15.823B 16.35
DaVita (DVA) United States $11.969B 14.87
Chemed (CHE) United States $8.605B 26.67
Encompass Health (EHC) United States $8.603B 22.02
Elanco Animal Health (ELAN) United States $8.391B 21.77
Option Care Health (OPCH) United States $5.187B 19.63
RadNet (RDNT) United States $4.254B 88.58
Amedisys (AMED) United States $3.103B 21.98
LifeStance Health (LFST) United States $2.817B 0.00
Astrana Health (ASTH) United States $2.304B 31.16
Addus HomeCare (ADUS) United States $1.805B 25.83
U.S Physical Therapy (USPH) United States $1.601B 42.84
Pennant (PNTG) United States $0.673B 35.57
Aveanna Healthcare Holdings (AVAH) United States $0.510B 0.00
Atai Life Sciences (ATAI) Germany $0.311B 0.00
Daxor (DXR) United States $0.045B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.028B 0.00
ATI Physical Therapy (ATIP) United States $0.022B 0.00
Ontrak (OTRK) United States $0.013B 0.00
Novo Integrated Sciences (NVOS) United States $0.010B 0.00
IMAC Holdings (BACK) United States $0.004B 0.00